Notice of Intent to Award a Sole Source for iCAD AI Mammography Software Licenses
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Department of Health and Human Services (HHS), specifically the Indian Health Service (IHS), has issued a Notice of Intent to award a sole source, firm-fixed-price purchase order to iCAD, Inc. for the renewal of iCAD AI Mammography Software Licenses. This requirement supports 3D mammography services at Fort Belknap Hospital, Harlem, MT. The service provides an essential AI platform for radiologists and includes critical software upgrades. Responses from interested parties are due by April 12, 2026, at 1:00 PM MST.
Scope of Requirement
The requirement is for the renewal and continuation of iCAD 2D/3D Detection Per Exam Licenses for the IHS's 3D Mammography (Digital Breast Tomosynthesis) suite. This Artificial Intelligence (AI) platform serves as a concurrent reading tool, aiding radiologists in interpreting mammogram studies. The service also includes necessary software upgrades to maintain diagnostic accuracy and security.
Contract & Timeline
- Type: Notice of Intent to award a Sole Source Firm-Fixed-Price Purchase Order
- Anticipated Awardee: iCAD, Inc.
- Duration: One 12-month base period with four 12-month option years
- Set-Aside: Not Applicable (Sole Source)
- Product Service Code (PSC): DA10 (IT and Telecom - Business Application/Application Development Software as a Service)
- NAICS Code: 513210 (Software Publishers)
- Response Due: April 12, 2026, 1:00 PM MST
Sole Source Justification
The sole source justification is based on:
- Proprietary Technology: iCAD, Inc. exclusively owns and developed the FDA-cleared deep-learning algorithm. No other vendor is licensed to sell or provide mandatory upgrades.
- Continuity of Service and Patient Data: The existing iCAD cloud service hosts historical Protected Health Information (PHI). Migrating this sensitive data to an alternative vendor poses unacceptable risks of data loss or corruption, compromising patient care and diagnostic integrity.
- Avoidance of Unacceptable Risk and Cost: Switching vendors would necessitate a complex, high-risk, and costly data migration, leading to significant operational downtime and substantial HIPAA security risks.
Submission Details
This is a Notice of Intent, not a Request for Quotation (RFQ); a solicitation will not be issued. However, responsible sources who believe they can meet the requirement may submit a capability statement, proposal, or quotation. Responses should include sufficient technical information for government review and determination of capability. Submissions must be sent electronically to the primary point of contact.
Point of Contact
- Name: Jesse Weidow, Contract Specialist
- Email: Jesse.Weidow@hhs.gov